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Abstract 
 
Background 
Severe head injury (HI) has been shown to be a trigger for neurodegeneration (Gupta, 
2016) while research into predictors of cognitive decline has found walking speed to be a 
useful predictor of changes in cognition over time. It is therefore important to explore what 
we know about whether walking speed could predict cognitive decline in this ‘at risk’ 
group after a head injury.  Little research has been reported on HI and this review is 
broadened to include any acquired brain injury (ABI). 
 
Research Question 
Can walking speed screen for cognitive function in people who have experienced an ABI? 
 
Methods 
A systematic search of the literature was conducted to identify available literature which 
explored an association between cognition and walking speed in those who had 
experienced an ABI.   
 
Results 
The search identifies five articles that meet inclusion criteria; four include participants with 
a stroke, and one, participants with head injury (HI). The papers are evaluated for quality 
and a narrative synthesis is used to combine and interpret the results.  There is not enough 
evidence to reach conclusions about people who have experienced a HI, however some 
evidence suggests that walking speed could be a useful predictor of cognition over time 
following a stroke.  The importance of considering time post stroke and the use of walking 
speed as part of a dual task are discussed. 
 
Significance 
Walking speed offers the potential of a quick, easy and naturalistic method of detecting 
risk for cognitive change, hence exploring the potential role of walking speed in predicting 
this risk may have important clinical and research implications. 
 
Keywords: walking speed; dual task; ABI. 
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Introduction 
 
Head injury and cognitive decline  
It has been argued that severe head injury (HI) is a major global health and socioeconomic 
problem which can act as a trigger for neurodegeneration and cognitive impairment 
(Gupta, 2016). Dunning et al (2016) conducted a meta-analysis of 21 studies, in HI 
survivors.  When compared to controls, those with a HI had significant deficits in memory 
and visuospatial skills. Fann et al (2018) conducted a nationwide population based 
observational cohort study in Denmark using national data on 2,794,852 people.  They 
found that head injury was associated with an increased risk of dementia when compared 
to those without HI and this enhanced risk can cause ongoing concern to the individual and 
their loved ones. 
There is currently a great deal of interest around the neuropathology of HI and cognitive 
decline.  Iverson et al (2015) completed a review of chronic traumatic encephalopathy 
(CTE) which is considered a type of dementia associated with repeated head injuries and 
repeated episodes of concussion.  They reported that it was still unclear whether it is HI 
that leads to cognitive decline, where the neurotrauma itself causes cognitive impairment, 
or whether the HI is instead associated with reductions in cognitive reserve which make the 
person then vulnerable to an earlier expression of a degenerative disorder. This leads to 
controversy around whether CTE is a separate disease process or a contributor to a known 
disease process. Alternative theories also suggest that there may be an independent third 
factor of importance; a risk factor which increases a person’s chance of having both a HI 
and cognitive decline.  McMillan et al (2014) found that poorer health prior to injury was 
associated with mortality late after mild HI and so there may be health related factors 
which make people more vulnerable to both HI and cognitive decline.  Gupta argues that 
there is a need to understand this process more fully with improved accuracy of clinical 
diagnostic criteria for HI induced diseases.  
Gait and cognitive decline 
Research into predictors of cognitive decline has explored the importance of gait, in 
particular walking speed.  Miekle et al (2012) conducted a large population-based study 
(n=1478) on walking speed as a predictor of cognitive decline. They found that faster 
walking speed was associated with better performance in memory, executive function and 
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global cognition when followed for 20 years. This is in line with findings from other 
studies showing an association between walking and cognition (Callisaya et al, 2015 & 
Verghese et al, 2007).  
Buracchio et al, (2010) explored the trajectory of gait speed preceding mild cognitive 
impairment (MCI) and found that gait speed slowed up to 12 years before MCI.  They 
argue that motor function may be useful in early detection of dementia when the benefits 
of intervention would be greatest.   
Research has tried to explore why walking speed might predict cognitive decline.  Some 
theories suggest that the changes to the brain which lead to cognitive decline affect 
walking speed early in the process.  Magnetic resonance imaging scans have been found to 
show periventricular white-matter sensitivities which are associated with slower of walking 
speed (Camiciolio et al, 1999).  Walking speed therefore could be an indicator of a neural 
problem associated with future cognitive decline.  Montero-Odasso & Hachinski (2014) 
argue that brain cortical control of both gait performance and cognitive function such as 
executive function share the same brain networks.  They argue that these brain networks 
are highly susceptible to microvascular damage, thus affecting both cognition and gait.  
While Hausdorff (2005) argues that the processes involved in walking are automatic, 
requiring little cognitive input.  They argue that when this automaticity is impaired, for 
example if someone has a degenerative disease, then walking is impaired. Alternative 
theories suggest the potential importance of a common shared factor affecting both 
walking speed and cognitive decline.  Alfaro-Acha et al (2007) describe one potential third 
factor as muscle strength.  Muscle strength has been shown to be highly correlated with 
walking speed in disabled older women (Rantanen et al, 1998), as well as blood markers 
which have been shown to contribute to cognitive decline in Alzheimer’s Disease 
(Hogervorst et al, 2004).   
Measuring walking speed 
In addition to looking at walking speed alone, some studies also investigate walking speed 
as part of a dual task procedure.  A dual task (DT) procedure requires an individual to 
perform two tasks simultaneously, and can be compared to performance in single task (ST) 
conditions (McCulloch, 2007), allowing by subtraction, a response cost to be calculated.  
An example would be asking someone to walk (ST), then count backwards from 100 in 3s 
(ST) then do them both at the same time (DT).  Reduced performance in the DT condition 
is described as dual task cost (calculated as DT-ST/ST). Dual task cost may represent 
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impaired capacity to share cognitive resources between walking and an attention 
demanding task.  Measures of dual task were developed following clinical observation that 
some frail elderly patients would stop walking when they were talking, and this was 
associated with falls risk (Lundin-Olsson et al, 1997).  A recent review demonstrated the 
ecological validity of dual task measures (McFadyen et al, 2017), while others have argued 
that short walking tests alone are redundant (Dobkin et al, 2006).  
Gait and head injury 
Biomechanical deficits are common following HI (van Donkelaar et al, 2006). Williams et 
al (2009) aimed to identify the most common gait abnormalities in this group.  They 
recruited 41 ambulant participants who were receiving therapy for gait abnormalities 
following HI. They found that the most common abnormalities were related to trunk and 
pelvic movements.  They also compared the sample to healthy controls and found that 
those with HI walked significantly slower than the controls, due to a reduced rhythm and a 
shorter step length. The higher prevalence of walking difficulties in this population leads to 
an interesting theoretical question around whether this impacts the potential usefulness of 
walking speed as a predictor of cognitive decline in this group.   If it were established that 
walking speed predicts cognitive change in this at risk group, then it could be used as a tool 
to triage patients presenting in primary care to further screening of neuropsychological 
assessment.  This would help ensure they received an appropriate intervention as quickly 
as possible. 
Aims 
This review sought to explore the available evidence exploring an association between 
cognition and walking speed in those who have experienced an acquired brain injury 
(ABI).  Walking speed offers the potential of a quick, easy and naturalistic method of 
detecting risk for cognitive change hence exploring the potential role of walking speed in 
predicting this risk has important clinical and research implications.   Although it would be 
too restrictive to only include studies which utilised a dual task procedure, studies which 
included walking speed as part of a dual task are of particular interest for this review. 
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Research Questions: 
1. Is there an association between walking speed and cognitive function in people who 
have experienced an ABI? 
2. Can walking speed screen for cognitive function in people who have experienced an 
ABI? 
3. Can walking speed/cognition dual task screen for cognitive function in people who 
have experienced an ABI? 
 
Methods 
Search strategy: Studies were identified using the following electronic databases: Medline, 
EMBASE, Psych Info, Cochrane Library, Psychology and Behavioural Sciences and 
CINAHL.  All databases were searched on 2.10.17, with no time limit.  The search was 
carried out using subject headings and keywords (in title, abstract and keyword) separately 
and then combined.  The following search terms were used (Table 1): 
Table 1.  Search strategy 
 
The three searches in Table 1 were conducted separately and then combined (1 AND 2 
AND 3).   The final search strategy was individualised to ensure suitability across each of 
the databases and was developed with the support of a librarian.   
Selection criteria: Following completion of the search and removal of duplicate articles, 
studies identified were screened in line with the following inclusion and exclusion criteria.  
 1. Walking 
speed 
2. Acquired Brain 
Injury 
3. Cognition 
S
u
b
je
ct
 h
ea
d
in
g
s 
• Walking 
• Gait 
• Ambulation 
• Walking speed  
 
• Brain injury 
• Head injury 
• TBI 
• ABI 
• Stroke 
• cardiovascular accident 
• CVA 
• Hypoxia 
• Encephalitis 
 
• Cognition 
• Cognitive decline 
• Cognitive change 
• Cognitive deterioration 
• Cognitive impairment 
• Cognitive dysfunction 
• Cognitive function 
K
ey
w
o
rd
s 
 
((walk* or gait) N5/ 
adj5 (speed or 
pace)) 
 
 
((brain or head) N2/adj2 
injur*) or TBI or ABI or 
stroke or cardiovascular 
accidentor CVA or 
hypox* or encephal* 
 
 
(cognit* N5/adj5 (chang* 
or declin* or deteriorat* 
or impair* or 
dysfunction* or 
function*)) 
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To be included, the paper had to include a sample of adults (aged over 15 years) who had 
experienced an ABI, defined as any single neurological event injury of acute onset.  The 
participants must have undergone a measure of walking speed and a measure of cognition, 
and so all had to be able to walk a short distance.  In addition, the paper had to provide (or 
be made available upon request to the research team) analysis exploring relationships 
between walking speed and cognition.  The paper had to be published in the English 
language in a peer reviewed journal.   
Articles were excluded if they did not meet inclusion criteria or if including participants 
with congenital (e.g. Down’s syndrome) or neurodegenerative conditions (e.g. dementia or 
multiple sclerosis).   For those with an ABI, studies with participants who had brain 
damage as a result of long term decline, for example, due to alcohol use were also 
excluded.   
Search Results: After removing duplicates, 911 articles were identified.  Of these, 803 
were excluded on the basis of title, and a further 73 by abstract.  Thirty-five articles were 
read in full.  Of these, 30 were excluded because they did not include data exploring an 
association between cognition and walking speed. Five studies were included in the 
qualitative synthesis.  Data were extracted using a data extraction form (see appendix 1.2). 
This aimed to extract key information on participants, interventions, comparators, and 
outcomes (PICO).  The reference lists of these five papers were then read, but no 
additional articles that met the inclusion criteria were identified at this stage.  The search 
was re-run on 3.5.18, to search for articles published from 2017 onwards and no further 
articles that met the inclusion criteria were identified.  Hence five studies were included in 
the final review (see figure 1).   
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Figure 1.  PRISMA flowchart 
Rating risk of bias: Papers selected for inclusion were systematically rated for 
methodological bias using criteria developed for observational studies in epidemiology 
(Sanderson et al, 2007) in six key domains (see appendix 1.3).  This method was used by 
Moynan & McMillan (2017) in their systematic review exploring the prevalence of head 
injury and associated disability in prisoners. The following defines low risk of bias for 
each domain: 
 
Methods for selecting study participants 
• Inclusion and exclusion criteria are clear and adequate assurance they meet criteria 
of having experienced an ABI. The sample is representative of the ABI population 
group it includes.   
Methods for measuring exposure and outcome variables 
• Use of standardised measures for both walking speed and cognition. 
Design specific sources of bias 
• Appropriate methods outlined to deal with any design specific issues such as biased 
loss to follow up or blinding.   
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Methods to control confounding 
• Appropriate consideration of potential confounders on the relationship between 
walking speed and cognition. 
Statistical methods 
• Appropriate use of statistical analysis. 
Conflict of interest  
• Declarations of conflict of interest and identification of funding sources. 
Each paper was assessed by two independent raters in each of the six domains as having a 
‘high’ or ‘low’ risk of bias.  In cases where it was unclear, e.g. no details provided on 
blinding, but unclear whether blinding would be necessary, were rated as ‘unclear’. Raters 
were both trainee clinical psychologists and interrater concordance was 27/30 (90%), with 
the three discrepancies resolved with discussion.  
Results  
All the studies consist of a sample of people who have had a stroke, apart from Cantin et al 
(2007) which has a HI sample.  Table 2 shows the risk of bias across each of the five 
included studies. Apart from low bias in Ben Assayag et al (2015), risk of bias was mixed 
for the other domains.  Table 3 documents characteristics of the participants while table 4 
provides information about the study methods and results.  
There was a range of ages included, with the mean age ranging from 37.7 to 70 years 
(individual sample age ranges not always provided).  There was a higher percentage of 
men in each of the studies.  This is likely to reflect the higher prevalence of HI in men than 
women in the wider population (Frost et al, 2013), and the higher prevalence of men than 
women (aged under 75) who have a stroke (Rosamond et al, 2007).  
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Table 2.  Risk of bias 
Authors 
(year) 
Methods for 
selecting 
participants 
Methods 
for 
measuring 
exposure 
and 
outcome 
variables 
Design 
specific 
sources 
of bias 
Methods to 
control 
confounding 
Statistical 
methods 
Conflict 
of 
interest 
Arsic et al 
(2015) 
High Low Unclear Low Low Low 
Ben Assayag 
et al (2015) 
Low Low Low Low Low Low 
Cantin et al 
(2007) 
High High Unclear High Low Low 
Sagnier et al 
(2017) 
Low Low High Low Low Low 
Taylor-Pillae 
et al (2012) 
Low Low High High Low Low 
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Table 3.  Data extracted from included studies- Participants 
 
 
 
Author 
(Year) 
ABI Sample 
size 
(ABI) 
Time since ABI % 
male 
Mean (SD) 
age (years) 
Arsic et 
al (2015) 
Ischemic stroke 
patients in 
subacute phase 
with hemiparesis  
50 Range unknown.  
All had undergone 
early rehabilitation 
and were continuing 
with further 
rehabilitation. 
52 69.9 (7.71)  
Range: 
50-80 years 
Ben 
Assayag 
et al 
(2015) 
First ever, mild-
moderate 
ischemic stroke or 
transient ischemic 
attack 
298 Neuropsychological 
data at point of 
hospital admission 
(within 72 hours of 
symptom onset) 
62 66.7 (9.6) 
Cantin et 
al (2007) 
Moderate or 
severe HI, mean 
(SD) Glasgow 
Coma Scale = 7.6 
(2.6) 
10 Time since injury:  
Range= 30-861 days,  
Mean (SD)= 5.4 (8.4) 
months  
80 37.7 (13.7) 
Sagnier et 
al (2017) 
Supratentorial 
ischemic stroke.  
Large-artery 
atheroscelorosis 
(14%), 
Cardioembolism 
(26%), small 
vessel disease 
(9%), other (4%), 
undetermined 
(47%). 
212 Recruited at hospital 
admission.  Baseline 
data 24-72 hours 
from onset.  
71 64 (13) 
Taylor-
Pillae et 
al (2012) 
68% ischemic 
stroke, 31% 
hemorrhagic 
stroke 
100 Months post stroke 
Range= 3-356 
Mean (SD)= 39 (49) 
54 70 (10) 
 
 
 
 
Table 4.  Data extracted from included studies- methodology and results 
Authors 
(year) 
Key inclusion/exclusion criteria Measures Key findings 
Arsic et al 
(2015) 
Inclusion-stroke patients with hemiparesis 
who had received early rehabilitation 
Walking speed-The Functional 
Ambulation Categories (FAC) is a 
functional walking test that includes a 
measure of walking speed; m/s over 3 
metres.  
 
Cognition-MMSE 
Mean (SD) MMSE score- 22.72 (3.33) 
Mean speed of gait (m/min)- 75.46 (23.1) 
 
MMSE is not significantly correlated with walking 
speed (r=.228, p>0.05). 
Ben 
Assayag 
et al 
(2015) 
Inclusion- First ever, mild-moderate 
ischemic stroke or TIA. 
 
Exclusion- if they had haemorrhagic 
stroke, stroke resulting from trauma or 
invasive procedures, severe aphasia, 
CD/dementia, or were unlikely to be 
discharged from hospital or participate in 
hospital. Patients with gait dysfunction 
were also excluded.  
Walking speed- Speed over 20 metres 
 
Cognition-MoCA and Neurotrax 
(computerised battery) 
Mean (SD) 6 month MoCA score- 25.3 (3.3) 
Mean (SD) 6 month walking speed (m/s)- 1.3 (1.8) 
 
Walking speed correlates significantly with MoCA 
scores 6 months (r=.509, p<0.01) and 24 months 
(r=.470, p<0.01) post stroke. 
 
46 participants (15.4%) developed clinically 
significant cognitive decline during 2 year follow up. 
Walking speed predicts cognitive decline over 24 
months (Relative Hazard Ratio=4.61 95 % confidence 
interval: 2.19-9.67, P<0.001*). 
Cantin et 
al (2007) 
Inclusion- Experienced only 1 HI with 
severity ratings of moderate to severe on 
the Glasgow Coma Scale.  Able to walk 
with a minimum speed of 0.7m/s without 
any walking device or assistance. 
 
Exclusion- subjects with skull fractures or 
perforations, severe cognitive or 
behavioural problems adversely affecting 
Walking speed- Included in locomotor 
patterns assessment 
 
Cognition- trails, SDMT, Digit span, 
STROOP, D2 test, Brown Peterson 
test, letter number sequencing 
Mean (SD) scores for Trails A (seconds), 41 (22.49), 
Trails B (seconds), 110.56 (51.21), digit span forward 
(number), 8.9 (2.6), digit span backward (number), 5.3 
(2.11), Stroop colour (seconds), 74.89 (8.82), Stroop 
word (seconds), 56.9 (7.33), Stroop interference 
(seconds), 123.4 (24.47), spatial span forward 
(number), 8.7 (2), spatial span backward (number), 8 
(1.63), SDMT (number), 38.2 (6.32), letter-number 
sequencing (number), 8.8 (2.49), D2 test (number) 
 
 
 
 
the ability to participate, or 
musculoskeletal problems affecting 
locomotion. 
total, 381.9 (63.65), errors, 23.3 (32.06), Brown 
Peterson Test (number), 13.2 (4.85).   
 
“no significant relationships were shown between 
walking speeds and results on neuropsychological 
exams”- no statistical analysis provided 
Sagnier et 
al (2017) 
Inclusion- adults diagnosed with a 
supratentorial ischemic stroke between 24 
hours and 72 hours from onset and with a 
National Institute of health stroke score 
comprised between 1 and 15. 
 
Exclusion- pre-stroke modified Rankin 
scale >1, pre-stroke dementia, axis 1 
psychiatric disorder, history of chronic 
disease compromising patient’s follow up 
at 1 year, and incapacity to perform the 
tests due to severe hemiplegia or aphasia. 
Walking speed- 10m walking test (10-
MWT) 
 
Cognition- MoCA 
Mean (SD) MoCA score  
 -baseline- 22.1 (6.3) 
 -3 months -24.3 (4.6) 
 -one year - 25 (4.1) 
 
Mean (SD) 10-metre walking time (seconds) 
- baseline – 11.9 (3.7) 
- 3 months – 9.7 (3.9) 
-12 months – 9.9 (4.9) 
 
Change in walking speed is associated with change in 
MoCA score at 1 year post stroke (estimate β= 0.2, (-
0.24; -0.07), p<0.01)) 
Taylor-
Pillae et 
al (2012) 
Inclusion- community-dwelling stroke 
survivors.  First 100 to enrol in an 
exercise intervention study  
Walking speed-4m gait speed test 
 
Cognition- MMSE 
Mean (SD) MMSE score- 27.9 (2.2)  
Mean (SD) gait speed (m/s)- 0.7 (0.3)  
 
Walking speed correlates weakly but significantly with 
MMSE (r=0.2, p<0.05). 
MMSE- Mini Mental State examination, MoCA- Montreal Cognitive Assessment, SDMT- Symbol digit modalities test, CD- cognitive decline, TIA- Transient ischemic 
attack 
*This result is not identified as significant in the published paper.  Correspondence with the author confirmed a typing mistake and confirmed this as a significant result. 
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Summary of studies  
Arsic et al (2015) explored whether there was an association between walking speed and 
cognition in 50 stroke patients.  They found no significant correlation between walking 
speed and Mini Mental State Examination (MMSE) score.  There was however a high level 
of bias in recruitment of participants, all of whom had undergone early rehabilitation post-
stroke.  The paper does not state exclusion criteria, or provide any details around the larger 
sample from which it is recruited or recruitment rates.  It is therefore unknown how 
representative it is of the wider stroke population. The modest sample size also limits 
confidence in interpretation.  Walking speed during a dual task procedure was not 
included.  
Ben Assayag et al (2015) explored both how gait speed and cognition were correlated after 
stroke and if gait speed could predict cognitive decline in the two years following a stroke.  
They found that gait speed and Montreal Cognitive Assessment (MoCA) scores had 
moderate correlations at both 6 and 12 months post stroke and that gait speed predicted 
cognitive decline.  There was no evidence of risk of bias in this study.  This study also 
utilised a dual task procedure, where people were asked to walk while counting backwards 
from 100 in 3s. They found that using this procedure, the number of correct responses 
given during this dual task significantly correlated with MoCA scores 6 and 24 months 
after stroke and predicted cognitive decline over 2 years.   
Cantin et al (2007) explored correlations between gait speed and cognition in 10 patients 
following a traumatic brain injury.  They did not provide any specific results for this 
analysis but reported that no significant associations were found across a range of 
cognitive measures.  There was a high risk of bias noted in this study, with a small sample 
size, no global measure of cognition, and no evidence that potential confounders on the 
relationship had been considered. Walking speed during a dual task procedure was not 
included in this study. 
Sagnier et al (2017) reported significant associations between changes in walking speed 
and changes in MoCA scores one year after stroke.  High risk of bias however was noted in 
this study when considering loss to follow up. Although the study included data from 212 
participants, the study only included results for participants with complete longitudinal 
data.  It is therefore unknown how representative this is of the larger stroke population and 
some of the factors which may have led to participants not remaining in the study.  
Walking speed during a dual task procedure was not included in this study. 
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Taylor-Pillae et al (2012) explored how walking speed and cognition were associated in 
100 patients who had experienced a stroke.  They found a weak correlation between 
walking speed and MMSE score.  There were potential sources of bias noted however; 
high levels of missing data, only including those with complete data and not including age 
as a potential confounder.  Walking speed during a dual task procedure was not included in 
this study. 
Overall, these studies provide a range of results around a potential association between 
walking speed and cognition following ABI.  Findings are difficult to generalise because 
the study designs vary, as do the participants they include, the measures they use and the 
questions they attempt to answer and so it is not possible to combine results to explore 
overall results across studies.  Of particular interest are studies which include a measure of 
walking speed as part of a dual task procedure, however only one study included this.  
Discussion 
A systematic search of the literature to identify articles which explored a potential 
association between walking speed and cognition in a sample of people who had 
experienced an ABI found five articles which met inclusion criteria. With due 
consideration of potential sources of bias, the results can be interpreted to help us answer 
the research questions.  
Is there an association between walking speed and cognitive function in people who 
have experienced an acquired brain injury? 
Together the studies comprised 660 participants who had experienced a stroke and ten 
participants who had experienced a HI.  There is insufficient evidence to come to any 
definite view about HI. It is clear that this is an area which requires further research given 
interest in long term decline after HI (Millar et al, 2003).   
Research on stroke participants suggest a link between walking speed and cognition. Ben 
Assayag et al (2015) included the largest sample and had the least risk of bias and found 
evidence for a moderate correlation at both 6 and 24 months post stroke.  Of note, the 
association was smaller after 24 months than 6 months which may reflect a reduction in the 
strength of the association over time.  Arsic et al (2015) did not find a correlation between 
MMSE and walking speed after stroke.  However, this study included people at varying 
times after experiencing a stroke and did not consider this potentially important factor in 
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their analysis.  Their lack of significant findings may be a reflection of the importance of 
length of time following a stroke when considering study results.  Delaveran et al (2017) 
conducted a study suggesting that the MoCA may be more suitable than MMSE to detect 
long-term post stroke cognitive impairment, as it was found to have increased sensitivity 
and did not have a ceiling which was found in the MMSE.  This finding may be important 
when interpreting our results and may explain the larger effect seen in studies using the 
MoCA as opposed to the MMSE.  With the limited number of studies available, it is not 
possible to fully explore the impact of the cognitive measure used or the impact of the 
length of time following injury. Future research would need to explore these issues more 
fully before conclusions can be drawn.    
Can walking speed screen for cognitive function in people who have experienced an 
acquired brain injury? 
Two studies explored longitudinal data.  These studies explored whether walking speed 
predicts cognitive change over time following stroke.  Ben Assayag et al (2015) found that 
gait speed 6 months after stroke predicted cognitive decline (cognitive impairment or 
dementia) 2 years after stroke, while Sangier et al (2017) found that changes in walking 
speed were associated with changes in MoCA one year after a stroke.   
Overall, both studies had reasonable sample sizes (200+) and included participants who 
had experienced a minor stroke (Median National Institutes of Health Stroke Scale  
(NIHSS) score of 2 in Ben Assayag et al, 2015, and a mean NIHSS score of 3.7 in Sagnier 
et al, 2017).   Although both studies utilised different methods, they are consistent in 
finding that walking speed is a useful measure of cognitive function up to 2 years 
following a stroke.  Of particular note, the study by Sagnier et al (2017) only included 
participants who completed all measures, with no evidence that drop out was considered.  
This is in contrast to the study conducted by Ben Assayag who compared the participants 
who completed the study with those who did not and found no significant difference 
between the groups.  This is important and provides us with important evidence that their 
results are likely to be representative of the original sample.  Overall, this evidence 
suggests that walking speed may be a useful indicator of cognitive decline following a 
stroke.  These studies only include follow up for two years, and so future research should 
explore whether walking speed is useful at predicting longer term outcomes for these 
patients.   
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Can walking speed/cognition dual task screen for cognitive function in people who 
have experienced an acquired brain injury? 
One study (Ben Assayag et al, 2015) used a dual task procedure in addition to the single 
task analysis. The number of correct responses during the dual task significantly correlated 
with MoCA scores 6 months (r=0.295, p<0.05) and 24 months (r=0.279, p<0.05) after 
stroke and predicted cognitive decline over 2 years (relative hazard ratio; 2.39 (1.16-4.93), 
p<0.05).  It may be that future research should explore the potential for walking speed as 
part of a dual task procedure to be used as a predictor for cognitive decline in those who 
have experienced a head injury.  
Results in context 
When considering these results within the wider context, it is important to consider how 
they compare with studies in other participant groups and in what way an ABI sample may 
be similar or different.   
Miekle et al (2012) conducted a large population based study (n=1478) on walking speed 
as a predictor of cognitive decline, in adults from the general population aged 70-89 years.   
They found that faster walking speed was associated with better performance in memory, 
executive function and global cognition when followed for 20 years.  Callisaya et al (2015) 
included a sample of 284 adults aged 60-85 years, to explore how gait speed was 
associated with cognitive decline over three years.  They found that a decline in executive 
function was associated with a decline in gait speed, with a stronger association where 
participants were already showing signs of cognitive impairment at baseline.  Verghese et 
el (2007) conducted a community based study with 399 participants aged over 70 years 
old.  Over five year follow up, 33 participants developed dementia and this study found 
that those participants had significantly slower walking speed at baseline when compared 
to the group who did not develop dementia during follow up.   
These studies provide evidence that walking speed can be associated with cognition over 
time.  All participants in these studies were recruited from the general population which 
marks a clear difference from those included in this review; all of whom had an ABI.  The 
studies in this review were predominantly on people who had experienced a stroke- with 
variability in time between the stroke and the assessment. This review aimed to explore the 
potential utility of walking speed as a predictor of cognitive change over time; however 
these studies may include people who experience a rapid change in cognitive function 
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following initial assessment.    When considering the impact of a stroke on an individual it 
is likely that many would show cognitive improvement following an early initial 
assessment.  This contrasts with population based studies that include older adults, where it 
would be unlikely for a person to show cognitive improvement over time.  It may be that, 
given the range in outcome following a stroke, it will be harder to unpick the usefulness of 
walking speed as a predictor of later cognitive function in this sample.  In addition, the 
picture is further complicated by the walking difficulties experienced by many following a 
stroke.  Factors which affect the person’s walking speed are far more complex in someone 
who has experienced a stroke than in the general population, with sufferer’s commonly 
experiencing muscle stiffness, weakness or complete lack of muscle control.  For future 
research it seems important to consider when the baseline assessment takes place. 
Consideration will need to be given to when one might expect walking speed following an 
ABI to be a useful indicator of the person’s current or future level of functioning, with the 
majority of recovery occurring in the first three months post stroke (Skilbeck at al, 1983; 
Krakauer et al, 2015). 
Limitations 
There are limitations of this review which should be acknowledged.  Although the primary 
goal of this review was to identify research with a HI sample, the findings showed that 
there was only one study including a HI sample.  This particular paper had high risk of 
methodological bias and failed to provide any research data in support of their findings 
thus making it impossible to draw any meaningful conclusions about this population group.  
As it had been predicted that HI research would be limited, the search was extended to 
include participants with any ABI.  The search however only identified studies including 
people who had experienced a stroke therefore making any conclusion about ABI more 
generally impossible. When reviewing the four papers that included participants who had 
experienced a stroke, risk of methodological bias was noted in three of the four.   Although 
not a limitation of the review itself, this does lead to limitations around the reviews ability 
to answer the research questions with confidence.  Conclusions about the usefulness of 
walking speed as a predictor of cognitive decline following ABI as well as the potential 
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impact of existing walking difficulties in this population cannot be drawn with confidence 
and so remain questions for future research.  
Conclusions 
This review aimed to identify articles which explored an association between walking 
speed and cognition following ABI.  It sought to explore the evidence for an association 
between these factors and to explore whether walking speed could screen for cognitive 
function in people who had experienced an ABI.  Review of the five included articles 
suggests an association between cognition and walking speed following a stroke but did 
not provide enough evidence about the utility of walking speed as a predictor of cognitive 
decline in this sample to form a conclusion.  Evidence on HI was also insufficient for a 
view to be formed. The evidence that does exist is overall promising, and further research 
is required which should consider the use of walking speed as part of a dual task 
assessment.   
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Plain English Summary 
Cognitive decline late after head injury 
Background 
When someone experiences a severe head injury, it is known that they are at increased risk 
of cognitive decline later in life (Gupta et al, 2016). This can often occur long after the 
head injury and so can cause ongoing worry.  Research has tried to explore what may help 
predict who is at risk of cognitive decline. Findings show that slower walking speed can 
predict a decline in a person’s cognitive ability (Buracchio et al, 2010).  Although this has 
been shown in a number of studies, it has not been looked at in people who have had a 
severe head injury.  As these people are already at increased risk of cognitive decline it is 
important to explore whether walking speed also predicts decline in this group.   
 
Aims and questions 
To determine whether walking speed is associated with cognitive change late after severe 
head injury.    Will walking speed predict how a person’s cognitive ability changes over 
the next two years? 
 
Methods  
This study included 48 participants who experienced a severe head injury 20-40 years 
previously and who took part in an initial assessment assessing their walking speed and 
cognitive ability. Participants were asked to consent to undergo a second assessment, 2 
years later, to re-assess their walking speed and cognitive ability.  Statistical analyses were 
used to explore whether walking speed at the first assessment predicted any change in 
cognitive ability between the first and second assessment. 
 
Main findings and conclusions 
This study found that over a 2 year period, the sample overall did not show cognitive 
decline.  This made it difficult to know whether walking speed would have detected a 
change in cognitive ability in this group. As part of the walking task, participants were 
asked to count backwards from 100 in 3s while walking (dual task).  The results showed 
that people who counted more slowly during this task were more likely to show decline in 
some of the cognitive measures.  This shows that this dual task may provide us with 
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important information about ongoing cognitive functioning.  As those with HI are at risk of 
cognitive decline, it is important that future research explores this further. 
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Abstract 
Background 
Severe head injury (HI) can be a trigger for neurodegeneration (Gupta, 2016) and research 
into predictors of cognitive decline has found walking speed to be a useful predictor of 
changes in cognition over time. It is therefore of interest to explore whether walking speed 
could predict cognitive decline within this ‘at risk’ group.   
 
Research Question 
Can walking speed during dual task be used as an assessment for cognitive change late 
after severe head injury? 
Methods 
This study included 48 participants with a historic HI.  All had been assessed two years 
previously, completing measures of both cognition and walking speed as part of a dual 
task.  This study followed up these participants and repeated their baseline assessment. 
Regression analyses were used to explore whether the dual task measures at baseline 
predicted change in the cognitive measures between the baseline and follow up assessment.  
Results  
Overall the cognitive ability of the sample remained relatively stable over the two year 
follow up period. Although walking speed measures did not predict cognitive change, dual 
task counting and dual task cost (which include a measure of walking speed in their 
calculation) predicted change in the Mini Mental State Examination (MMSE) score and 
change in Symbol Digit Modalities score.  
Significance 
The dual task measure has potential to provide important information about ongoing 
cognitive functioning. Given that those who have experienced HI are at increased risk of 
cognitive decline, it is important that this potential is fully explored.   
Keywords: Walking speed; dual task; Head Injury; Cognitive decline 
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Introduction 
It has been argued that severe head injury (HI) is a risk factor for neurodegeneration late 
after injury (Gupta, 2016).  Dunning et al (2016) conducted a meta-analysis of 21 studies, 
in HI survivors.  When compared to controls, those with a HI had significant deficits in 
memory and visuospatial skills. The impact of HI may be long lasting and may put people 
at higher risk of cognitive decline later in life (Ozen et al 2015). Fann et al (2018) 
conducted a nationwide population based observational cohort study in Denmark using 
national data on 2,794,852 people.  They found that head injury was associated with an 
increased risk of dementia when compared to those without HI.  This large scale study with 
long term follow up clearly demonstrates the increased risk of dementia following HI and 
this enhanced risk can cause ongoing concern to the individual and their loved ones. There 
is currently a great deal of interest around the neuropathology of HI and cognitive decline.  
Iverson et al (2015) completed a review of chronic traumatic encephalopathy (CTE) which 
is considered a type of dementia associated with repeated head injuries and repeated 
episodes of concussion.  They reported that it was still unclear whether it is HI itself that 
leads to cognitive decline or whether the HI is instead associated with reductions in 
cognitive reserve which make the person then vulnerable to an earlier expression of a 
degenerative disorder.  Alternatively, there may be a third factor which makes people more 
vulnerable to both HI and cognitive decline, for example, poor health (McMillan et al, 
2014).  
Teasdale et al (1997) found that there may be genetic factors which affect outcome after 
HI, finding those who had an APOE genotype to be more likely to have a worse outcome 6 
months after injury.  Millar et al (2003) tried to explore whether this same genotype 
predicted cognitive decline after injury but concluded their sample with a mean age of 42 
years was too young to reach conclusions, suggesting this be explored further as the 
sample aged.  
Research into predictors of cognitive decline has explored the importance of walking 
speed.  Some studies look at walking speed alone while others utilise it as part of a dual 
task whereby participants are asked to walk while doing another cognitively demanding 
task, for example, talking.  Of the following six studies, two utilised a dual task procedure 
(Doi et al and Ben Assayag et al), whereas four looked at walking speed alone.  Miekle et 
al (2012) conducted a large population based study (n=1478) on walking speed as a 
predictor of cognitive decline. They found that faster walking speed was associated with 
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better performance in memory, executive function and global cognition when followed for 
20 years. This is in line with findings from a number of studies showing an association 
between walking and cognition (Callisaya et al, 2015 & Buracchio et al, 2010). This 
association has been shown in several diagnostic groups including those with mild 
cognitive impairment (Doi et al, 2014), stroke (Ben Assayag et al, 2015) and dementia 
(Verghese et al, 2007).  Two of these studies (Doi et al, Buracchio et al) looked at an 
association between walking and a measure of cognitive function.  The other four studies 
(Ben Assayag et al, Callisaya et al, Verghese et al, & Miekle et al) looked longitudinally at 
how walking was associated with cognitive decline over time. 
Research has tried to explore why walking speed might predict cognitive decline.  Some 
theories suggest that the brain damage or abnormality which leads to cognitive decline 
affects walking speed early on in the process while other theories attribute the link to a 
shared common factor, for example, muscle strength which has been shown to affect both 
walking speed in disabled older women (Rantanen et al, 1998) and blood markers which 
are linked to cognitive decline in Alzheimer’s Disease (Hogervorst et al, 2004).   
Biomechanical deficits are common following HI (van Donkelaar et al, 2006). Williams et 
al (2009) aimed to identify the most common gait abnormalities in this group.  They 
recruited 41 ambulant participants who were receiving therapy for gait abnormalities 
following HI. They found that the most common abnormalities were related to trunk and 
pelvic movements.  They also compared the sample to healthy controls and found that 
those with HI walked significantly slower than the controls, due to a reduced rhythm and a 
shorter step length.   With participants who have experienced a HI being at higher risk of 
having gait abnormalities, it is not known whether the association between walking and 
cognitive change shown in other groups will also be evident in people who have 
experienced a severe HI.   
Walking speed offers the potential of a quick, easy and naturalistic method of detecting 
risk for cognitive change.  It is known that those with severe HI are at increased risk of 
cognitive change over time (Millar et al, 2003; Whitnall et al 2006); hence exploring the 
potential role of walking speed in predicting this risk has important clinical and research 
implications. If it were established that walking speed predicts cognitive change in this at 
risk group, then it could be used as a tool to triage patients presenting in primary care to 
further screening of neuropsychological assessment.  This would help ensure they received 
an appropriate intervention as quickly as possible.  
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There are a number of methodological challenges associated with this area of work. When 
seeking to follow up those with HI over a long period of time, it must be acknowledged 
that this group is at risk of experiencing premature death.  McMillan et al (2011) conducted 
a 13-year follow up study and found a death rate of 30.99 per 1000 per year in the head 
injury cohort, as compared to a rate of 13.72 per 1000 per year in the community control 
sample. In addition they are more likely to experience disability (Whitnall et al, 2006), 
which may also affect recruitment for research.   This presents with a significant challenge 
when trying to follow up large samples over time, in particular when trying to obtain data 
from a representative sample.   
This study is keen to detect cognitive decline.  While research has shown that those with 
HI are at increased risk of cognitive decline later in life, it is not possible to predict when 
this decline will take place.  Where a sample includes people covering a wide age range, it 
is likely that the risk of accelerated cognitive decline is not consistent across the sample.  
Research therefore can only capture a snapshot of time, with uncertainty around the level 
of cognitive decline which would be expected within such a sample.  Any findings 
therefore must be interpreted with this in mind and with appropriate caution.  
Aims and hypotheses  
Aim 
The aim is to explore walking speed during dual task as an assessment for cognitive 
change late after severe head injury. If an association between walking speed and cognitive 
change is found, then an additional aim will be to investigate whether a walking speed cut 
off can be established to capture those with cognitive decline (i.e. with good sensitivity and 
moderate/ good specificity). 
Hypothesis 
Walking speed at baseline (as measured by a dual task) is associated with cognitive change 
(as measured by the difference in cognitive scores between baseline and 2-year follow up).   
 
Method  
Study in context 
Participants were recruited from two historical research cohorts that included people with a 
severe HI (Millar et al, 2003; Teasdale et al, 2005).  The study conducted by Millar et al 
(2003) comprised of a database of 1133 patients who had sustained a severe head injury 
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and had been studied in the acute stage in the Department of Neuropsychology, Institute of 
Neurological Sciences at the Southern General Hospital, Glasgow between 1968 and 1985.  
A cohort of 396 was then included in follow up study at a mean age of 18 years later.  This 
follow up study was primarily exploring long term neuropsychological outcome after head 
injury in relation to genetic risk factors.   The study conducted by Teasdale et al (2005) 
included a sample of 1094 patients following head injury admission to the same 
neuropsychological unit between 1996 and 1999.  This study followed patients up for 6 
months, again exploring the role of genetics in outcome after HI.  Both of these studies 
were interested in the association between the APOE genotype and outcomes following HI 
and this remains an interest for ongoing research within this sample.  Patients were 
recruited for further exploration into this possible association between 2015-2017.  This 
provided a unique opportunity to explore the current research question around the potential 
role of walking speed as a predictor of cognitive decline and so dual task walking measures 
were included in the baseline assessments.   
The study has ethical approval from the West of Scotland NHS Research Ethics committee 
(ref 14/WS/1145). 
Participants 
 One hundred and three participants from the original two cohorts were recruited and 
assessed in the first part of this current study (2015-2017) and were eligible to be contacted 
for two-year follow up (2017-2019).  A total of forty-eight participants were included in 
this study.  They all undertook assessments in both 2015/2016 and then in a follow up 
study two years later, in 2017/2018.  Recruitment is shown in the flowchart below (figure 
1).   
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Figure 1.  Recruitment flowchart 
Inclusion and exclusion criteria                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
Participants were eligible to be included if they took part in the baseline assessment in 
2015-17.  All had a history of severe HI and baseline data on their cognitive ability and 
walking speed.   All participants had to be considered capable of giving informed consent.   
 
Participants were excluded if they had suffered a serious neurological event since the 
baseline assessment (e.g. a stroke or further HI), a physical injury affecting walking or 
were not capable of being assessed. 
 
Design 
The study was a longitudinal within group study.  Walking speed at baseline was explored 
as a predictor of cognitive change at 2 year follow up.   
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Measures and materials 
Background questionnaire: This included basic demographic data, including the 
participant’s age, gender and occupation.  In addition, it explored whether the person had 
experienced any significant life events since their previous assessment.  
 
Walking measure 
Dual task: A dual task (DT) procedure requires an individual to perform two tasks 
simultaneously, and can be compared to performance in single task (ST) conditions 
(McCulloch, 2007), allowing by subtraction, a response cost to be calculated. In this 
instance, participants will first be timed to walk 6 metres (ST) and then to count backwards 
from 100 in 3s for 30 seconds.  In addition to completing these tasks singly, participants 
will also complete them simultaneously – the dual task (i.e. walking and counting at the 
same time).  In the DT condition, poorer performance in either walking and/or counting 
could occur. Reduced performance in the DT condition is described as dual task cost 
(calculated as DT-ST/ST). Dual task cost may represent impaired capacity to share 
cognitive resources between walking and an attention demanding task.   
A total of four scores were used from this test;  
Dual task walking speed- Time taken (seconds) to walk 6 metres while counting 
backwards; 
Dual task counting- The number of correct counting responses given while walking 6 
metres divided by the time taken for each individual’s dual task walk, resulting in the 
number of correct responses per second; 
Dual task walking cost- (Time to walk 6m while counting– time to walk 6m without 
counting) divided by time to walk 6m without counting; 
Dual task counting cost- (number of correct counting responses per second while walking- 
number of correct counting responses per second without walking) divided by number of 
correct counting responses per second without walking.  
 
Disability Assessment 
Glasgow Outcome Scale Extended (GOSE, Jennett & Bond, 1975): A global scale of 
functional outcome that uses a structured interview to rate patient status into one of eight 
categories of recovery. The GOSE has been shown to be a valid measure of outcome which 
is sensitive to change following both mild to moderate (Levin et al, 2001) and severe brain 
injury (Teasdale et al, 1998).   
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Cognitive measures 
The choice of cognitive measures was limited by the need to use the same tests as those 
used in earlier studies with this cohort.   
Mini Mental State Examination (MMSE, Folstein et al, 1975): A screening tool to assess 
general cognitive function.  It includes items of orientation, registration, short term 
memory and language functioning.   Participants are given a total score out of 30, with a 
score of 24 or above representing normal cognition.  The MMSE has been shown to be a 
reliable measure of cognitive change in older adults (Hensel et al, 2007). 
 
Logical Memory Test (WMS-R- Wechsler, 1987).  The test involves reading 2 short stories 
aloud to the participant.  The participant is asked to recall as much as they can about each 
story, both immediately and again after a thirty-minute delay.  The score used in this 
current study is the total score combining their immediate and delayed recall.  The logical 
memory test has been shown to help differentiate those with and without mild cognitive 
impairment (MCI) as well as predicting progression from MCI to Alzheimer’s disease 
(Rabin et al, 2009). 
 
STROOP test: A measure of inhibitory control where the participant is asked to name the 
colour a word is printed in when the word itself is the name of another colour.  The score is 
the number of correct responses within a two-minute period.  Slowing on the STROOP has 
been shown to relate to patterns of cognitive decline in adults with dementia (Koss et al, 
1984).   
 
Symbol digit modalities test (SDMT- Smith, 1982): A tool for measuring processing speed, 
which can be used to screen for cognitive impairment, the participant is asked to use a 
reference key to pair specific numbers with given geometric figures.   Participants are 
asked to try to pair as many number/figures as they can within 90 seconds.  The score is 
the number of correctly completed pairings.  The SDMT has been shown as a valid and 
reliable measure of cognitive function (Sheridan et al, 2006). 
 
Short-term Memory binding task (STMBT):  This computerised task investigates the 
retention of shapes, colours or combinations of shapes and colours.  Participants are shown 
two consecutive screens and asked to identify changes between the two displays.  These 
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displays show shapes which change in either their shape or colour or both.  When they 
change in both shape and colour this is a measure of shape-colour binding.  Impairments in 
memory binding have been shown to differentiate between the performance of people with 
Alzheimer’s disease and patients with major depressions (Parra et al, 2010).  As a newly 
developed measure, lacking the same reliability and validity data as the other cognitive 
measures, it was not combined with the other cognitive measures within the composite 
cognitive score. Scores were calculated for accuracy when remembering the shape alone, 
accuracy when remembering the shape and colour (memory binding) and the difference 
between the two scores; representative of a specific difficulty with memory binding.  
 
Procedure 
All participants recruited to the first phase of this study were asked to take part in a follow 
up assessment, approximately two years after their last (‘baseline’) assessment.  The 
follow-ups were carried out by the author from August/September 2017 alongside a 
research worker who was involved in the baseline study. The author completed 36 of these 
follow up assessments.  
 
All potential participants (n=103) were contacted by letter from Professor McMillan with 
the study information (appendix 2.3), 2 years following their baseline assessment.  They 
were asked to read the information and return the enclosed consent form (appendix 2.4) in 
a prepaid envelope if they wished to participate. They were then contacted by phone to 
ensure they met the inclusion criteria and to schedule the assessment.  Research 
assessments took place in the Clinical Research Facility within Glasgow Royal Infirmary. 
They were provided with travel expenses and supermarket vouchers (£20) to compensate 
them for their time. The data was stored securely in line with the Data Protection Act.   
 
Analysis 
The primary research question was to explore whether walking speed during DT predicted 
cognitive change late after HI.  Cognitive change was the primary outcome variable.  A 
composite score for cognitive ability was created by combining Z scores for performance 
on Logical Memory, STROOP and Symbol Digit Modalities Tests.  These were created 
using the mean and standard deviations of the whole sample at baseline for each test and 
subtracting the score for each participant from this and dividing by the standard deviation 
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of the sample. The z scores for these three tests were summed for each participant to give 
the composite score, a method used by Whitnall et al (2006) when exploring disability 
after HI. Composite scores were created for each of the two time points. Change in (i) this 
composite score, and (ii) change in MMSE score were the primary outcome variables 
measuring cognitive change. Patterns in the data were explored; assumptions to conduct 
regression were met (see appendix 2.5), and non-parametric tests were used as the data 
violated the assumption of normality.  
 
Descriptive statistics were used to describe the sample at both baseline and follow up and 
the data were explored for changes between the two time points.  Linear regression was 
used to explore whether the walking measures predicted change in cognitive scores over 
time. Those who showed decline in their walking speed were also compared with those 
who did not.  Those who showed a decline in their GOSE were compared with those who 
did not show decline on their GOSE; t-tests were used to explore whether these groups 
differed on the walking measures.   Following findings from the baseline data; additional 
analysis also used linear regression to explore walking measures as predictors of executive 
functioning.   
 
Sample Size Estimation: Brace et al (2009), argue that as a rule of thumb at least 10 times 
as many participants as predictor variables are needed and so with 4 predictor variables 
(dual task walking speed, dual task counting; dual task walking cost and dual task counting 
cost) the sample size of 48 is sufficient.   
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Results 
Participant Characteristics 
The follow-up sample comprised 48 participants aged between 19-96 years (mean age 
52.13, SD=15.82).  Thirty-three were male (69%). They represented a range in educational 
level (10-22 years of education, mean 14.22 years, SD=3.40), and a range in socio 
economic status (SIMD quintiles; 1 (most deprived) =25%, 2=15%, 3=13%, 4=15%, 5 
(least deprived) =32%).  
All participants had a moderate or severe head injury, between 19 and 46 years previously 
(mean 29.71 years previously, SD=8.51).  They showed a range in outcome after the head 
injury on the GOSE, as shown in table 1 below. Overall; at baseline 52% of the sample had 
made a ‘good recovery’ (7 or 8) and 48% were disabled (3-6). At follow up 40% had made 
a ‘good recovery’ (score of 7 or 8), and 60% were disabled (3-6).  
Table 1.  GOSE scores at baseline and follow up 
GOSE category Baseline Follow-up 
1- Dead 0 0  
2- Vegetative state 0 0  
3- Lower severe disability 4 (8.3%) 4 (8.5%) 
4- Upper severe disability 2 (4.2%) 4 (8.5%) 
5- Lower moderate disability 9 (18.8%) 9 (19.1%) 
6- Upper moderate disability 8 (16.7%) 11 (23.4%) 
7- Lower good recovery 15 (31.3%) 10 (21.3%) 
8- Upper good recovery 10 (20.8%) 9 (19.1%) 
 
Dual task scores 
Participants were asked to count backwards from 100 in 3s (single task) and were then 
timed to walk 6 metres (single task).  They were also asked to do both simultaneously 
(dual task). The results for both single and dual task are shown below (table 2).   
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Table 2.  Single task vs dual task scores 
Outcome Single task 
Median (IQR) 
Dual task 
Median (IQR) 
Difference 
Walking time 
(seconds) 
4.82 (1.64) 5.84 (3.08) Z= -5.84, p<0.01 
Correct counting 
response rate (correct 
responses per second) 
0.53 (0.29) 0.04 (0.39) Z= -1.04, p=0.30 
 
Participants were significantly slower at walking 6 metres when counting at the same time.  
Their counting rate was unaffected.  
Is walking speed at baseline associated with cognitive change between baseline and 2-
year follow up?  
At baseline, participants ranged in their time to walk 6 metres from 2.59 seconds to 15.85 
seconds (mean 6.68 seconds, SD 2.69).   
Cognitive change was assessed as the difference between baseline and follow up on the 
MMSE, STROOP, Logical Memory and SDMT (table 3). In addition, the STROOP, 
Logical Memory and SDMT were combined to form a composite cognitive score. There 
was no significant change in the scores, except for Logical Memory where performance 
was significantly better at follow up compared to baseline.   
Table 3.  Change in cognitive scores over two year follow up.  
Test Mean (SD)- 
Baseline 
Mean (SD)- 
Follow up 
Difference over time 
MMSE 28.81 (1.42) 28.77 (1.69) t(47)=0.20, p=0.85 
STROOP 83.91 (27.93) 90 (23.16) t(42)=1.28, p=0.21 
Logical 
memory 
12.94 (7.67) 15.10 (9.10) t(47)=2.81, p<0.01 
Symbol Digit 
modalities 
Test 
39.25 (11.13) 38.94 (12.47) t(46)=0.80, p=0.43 
Composite 
cognitive score 
0.2 (2.16) -0.04 (2.39) t(42)=1.49, p=0.143 
 
Linear regression was used to explore whether the dual task predicted a change in 
cognitive scores between baseline and follow up. Each dual task score (dual task walking 
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speed, dual task counting, dual task walking speed cost, and dual task counting cost) was 
explored as a potential predictor of change in cognition.  The outcome was the change in 
cognition score (follow up score minus baseline score).  Age and number of years of 
education were also added into the model.  This was initially completed for change in 
MMSE score.  
Table 4.  Dual task measures and change in MMSE scores.  Univariate Regression 
analyses 
Variable B SE B Significance 
Dual task walking speed -0.13 0.09 0.14 
Dual task counting 2.46 0.81 p<0.01 
Dual task walking speed cost -1.02 0.69 0.14 
Dual task counting cost -0.21 0.44 0.63 
 
Table 4 shows that when entered individually, dual task counting is the only measure that 
predicts change in MMSE score.  For every increase of 1 in the dual task counting score 
there is an increase in MMSE score of 2.46 points. The dual task variables were then 
entered together into the multivariable regression model (Table 5). Neither walking speed 
during dual task nor walking speed cost were significant predictors, but dual task counting 
and dual task counting cost were. When added in together, for every increase of 1 in the 
dual task counting rate we see an increase in MMSE score of 3.82 points and for every 
increase in the dual task counting cost, there was a decrease in MMSE score of 1.23 points.   
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Table 5.  Dual task measures and change in MMSE scores.  Regression analyses variables 
combined.  
Variable B SE B Significance 
Dual task counting 3.82 0.89 p<0.01 
Dual task counting cost -1.23 0.44 p<0.01 
Age -0.00 0.01 p=0.82 
Years of education 0.62 0.62 p=0.32 
Baseline MMSE score 0.47 0.14 P<0.01 
 
It was also of interest to explore whether dual task measures predicted change in the 
composite cognitive score using univariate analysis; none significantly predicted outcome 
(table 6).   
Table 6.  Dual task measures and composite cognitive score. Univariate regression 
analysis  
Variable B SE B Significance 
Dual task waking speed -0.05 0.07 0.47 
Dual task counting 0.36 0.73 0.63 
Dual task walking speed cost 0.00 0.53 0.99 
Dual task counting cost -0.28 0.32 0.38 
 
Using ROC curves, it was found that none of the dual task measures could be used as 
screening tools for change in MMSE (as measured by a decrease in score by 1SD, 1.4 
points).  The area under the curve was poor to meaningless for each of the dual task scores 
(walking speed 0.35; counting rate 0.65; walking cost 0.42; counting cost 0.34) confirming 
that dual task scores were not able to screen for change in MMSE.   
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Is a reduction in walking speed between assessment and reassessment associated with 
a greater decline in cognitive test performance? 
Walking speed during the dual task was assessed at both time points.  Within the sample, 
33 participants (73.3%) did not show a change in their walking speed between the two time 
points (scoring within 1 SD; 2.70 seconds across both time points).  Seven participants 
walked faster (decreasing the time to walk 6m by 2.70 seconds, 1SD) at follow up than 
baseline, while the remaining 5 participants (11.1%) walked at least 2.7 seconds slower at 
follow up than at baseline.   
Within the group who performed slower (n=5), reduction in walking speed was between 
2.70 seconds and 40.94 seconds slower (Mean=11.78, SD=16.34).   
Table 7 shows the group differences, when comparing those who showed a reduced 
walking speed between the two time points and those who did not.  There are no 
significant differences between the groups on their change in MMSE score or composite 
cognitive score.   
Table 7.  Change in cognitive measures and group differences between those who showed 
reduced walking speed and those who did not. 
 Same or 
improved 
walking speed  
N=40 
Decline in 
walking speed 
N=5 
Difference between 
groups 
Change in MMSE score 
Mean (SD)  
Range 
0.05 (1.43) 
-3 to 1 
-0.80 (1.64) 
-4 to 3 
t(43) = -1.23, p=0.22, 
d=0.55 
Change in composite 
cognitive score  
Mean (SD) 
Range 
-0.14 (1.07) 
-2.73 to 2.97 
-0.50 (0.86) 
-1.43 to 0.27 
t(38)=-0.57, p=0.57 
d=0.66 
 
Additional exploratory analysis 
Short-term Memory binding task (STMBT) 
The STMBT was used as an exploratory measure.  It was of interest whether dual task 
measures were associated with scores on this measure recently developed as an assessment 
for early decline in cognitive function (Parra et al, 2010).  The scores at both time points 
are shown below (table 8).   
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Table 8.  Short term memory binding task scores (accuracy) at baseline and follow-up 
STMBT score Mean (SD)- baseline Mean (SD)- 
Follow up 
Difference over 
time 
Shape memory 0.95 (0.09) 0.95 (0.07) t(41) =0.13, 
p=0.90 
Shape and colour 
(memory binding) 
0.91 (0.11) 0.87 (0.14) t(41)= 2.45, 
p<0.05, d=0.32 
Difference 0.04 (0.09) 0.08 (0.11) t(41)= 2.19, 
p<0.05, d=0.40 
 
Memory binding score is measured as accuracy rate and so the results show that 
participants were significantly less accurate in completing the memory binding task at 
follow up when compared to baseline.  The difference score indicates the difference 
between a person’s performance on the shape memory task and their performance on the 
shape and colour memory task.  A higher score indicates a higher level of specific memory 
binding difficulty and so it can be seen that the participants were more likely to show a 
memory binding difficulty at follow up when compared their performance at baseline.   
Linear regression showed that none of the dual task scores at baseline predicted change in 
any of the STMBT scores between baseline and follow up (see Appendix 2.6). 
Decrease in Glasgow Outcome Scale Extended Score 
Table 9.  Change in GOSE score between time points (n=47) 
Change in GOSE score  N (%) 
+1 7 (14.6) 
No change 31 (64.6) 
-1 5 (10.4) 
-2 2 (4.2) 
-3 1 (2.1) 
-4 1 (2.1) 
 
It was of particular interest to explore any potential role of dual task scores in those who 
have shown deterioration over the two year follow up.  Nine participants had a lower 
GOSE score at follow up when compared to baseline (table 9).  Exploratory analysis 
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considered whether there were any differences in walking variables between those who had 
deteriorated and those who had not.  
Table 10.  Differences in baseline dual task measures between those who deteriorate on 
the GOSE and those who do not. 
Dual task 
measure 
Deterioration in GOSE 
N=9 
No deterioration in GOSE 
N=36 
Difference 
between groups 
Dual task walking 
speed 
Mean (SD) 
6.86 (1.51) 6.59 (2.94) t (45) =0.26, 
p=0.79, d=0.12 
Dual task 
counting 
Mean (SD) 
0.47 (0.13) 0.61 (0.27) t (43)= -2.30, 
p<0.05*, d=0.68 
Dual task walking 
speed cost 
Mean (SD) 
1.05 (0.19) 0.98 (0.34) t (45) = 0.59, 
p=0.56, d=0.25 
Dual task 
counting cost 
Mean (SD) 
0.29 (0.52) 0.08 (0.51) t (43) = 1.07, 
p=0.29, d= 0.41 
*equal variances not assumed 
Table 10 shows that those whose GOSE decreased were significantly slower at counting 
during the dual task at baseline.   
Baseline data analysis  
During the analysis of these results, some additional data became available from the write 
up of the baseline study (n=125). McLean et al, (under review) report that an increase in 
dual task counting cost score predicts an increase in SDMT, STROOP and STMBDT 
scores, all considered measures of executive functioning.   
Although STMBT scores have already been explored within this sample, regression 
analyses were used to explore dual task scores at baseline as predictors of change in the 
STROOP and SDMT individually (as opposed to as part of a composite measure).  
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Table 11.  Dual task and executive functioning.  Univariate regression analysis 
 
 
 
Dual task counting cost score at baseline predicted change in SDMT score between 
baseline and follow up.   
 
  
 Variable B SE B Significance 
Dual task walking SDMT 0.08 0.38 0.83 
STROOP -1.29 0.85 0.14 
Dual task walking cost SDMT 0.47 2.99 0.88 
STROOP -2.81 7.26 0.70 
Dual task counting SDMT -2.55 3.77 0.50 
STROOP 15.59 9.40 0.11 
Dual task counting cost SDMT -4.28 1.69 <0.05 
STROOP -1.66 4.24 0.69 
 
 
45 
 
Discussion 
 
This study investigated whether walking speed measures predict cognitive decline in 
people who have experienced a HI.  Although walking speed itself was not shown to 
predict cognitive change, dual task counting and dual task cost (which include a measure 
of walking speed in their calculation) were found to predict change in MMSE score and 
change in SDMT scores.   
 
Previous research has highlighted the potential usefulness of walking speed in predicting 
cognitive decline, with longitudinal associations found both in the general population 
(Miekle et al, 2012) and in diagnostic groups including stroke and dementia (Ben Assayag 
et al, 2015; Verghese et al, 2007).  This study explored whether walking speed predicts 
cognitive decline in a different group; those with HI, however this was not found. Walking 
speed showed no associations with cognitive decline within this HI sample.  We cannot 
however conclude that walking speed is not a useful measure for people with HI, due to the 
limited cognitive change in the sample within the 2 year follow up period.  
 
In terms of cognitive change, the only score where a change was observed was an 
improvement in logical memory, which may be explained by a learning/practice effect.  It 
is therefore important to consider the possibility that cognitive change was not detected.  It 
may be that there was a recruitment bias, and those showing cognitive decline were less 
likely to be recruited to follow up.  Ongoing follow up will recruit more participants by 
offering home visits or phone interviews in addition to outpatient assessments.  This will 
allow this possibility to be explored more fully.   It is also possible that the tests were not 
sensitive enough to pick up cognitive decline.  This may be unlikely, due to the use of 
standardised measures, which have shown cognitive decline in older adults with and 
without cognitive impairment (Hensel, et al 2007; Rabin et al, 2009 & Koss et al, 1984).  It 
is therefore likely that the cognitive decline shown by participants is either too small or in 
too few participants to show cognitive change in the sample overall.  Ozen et al (2015) 
argued that a historic HI may place older adults at risk of accelerated age related cognitive 
decline later in life.  With the average age within this sample being 52 years it may be that 
they have yet to enter the period of accelerated cognitive decline.   
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Interpretation of dual task scores 
Dual task measures include both a walking and a counting task component.  When asked to 
do these at the same time, it is expected that either or both walking and counting will slow.  
When asked to complete two tasks simultaneously, without instruction, the person has to 
make a decision about which task to prioritise.  This study found that the participants were 
more likely to prioritise the cognitive task during dual task and in fact managed to maintain 
their counting rate between single and dual task counting, at the expense of walking speed. 
This is in line with what would be expected from previous research (Li et al, 2012).  
The results showed that although it was walking speed that was affected during the dual 
task, the dual task counting rate was more predictive of outcomes at follow up. As there 
was no difference between single task and dual task counting rate, the results showing the 
dual task counting rate as predictive of future outcomes are best understood as a reflection 
of the importance of the cognitive task itself, as opposed to how it is affected during the 
dual task.  It seems that being able to count backwards in 3s is predictive of later changes 
in cognition. 
Although not significant on its own, dual task counting cost became significant when 
added into a regression model alongside dual task counting rate.  It appears that a better 
picture of counting cost can be observed when counting rate is adjusted for. Dual task 
counting cost was also found to predict change in SDMT.  Although most participants 
displayed dual task walking cost, as opposed to dual task counting cost, it appears that, 
where there is a dual task counting cost that this is predictive of cognitive change.  This 
can be seen both globally, as captured by the MMSE, and in processing speed as captured 
by the SDMT; which has been shown as a valid and reliable measure of cognitive function 
(Sheridan et al, 2006).   
 
Limitations 
Potential limitations of the study included a modest sample size, which could have left the 
study underpowered.  While ideally studies would include much larger samples, the 
complexity and associated challenges of recruiting those with HI to long-term follow up 
prohibits this. Therefore, it is important to strive to explore this within small samples, but 
interpret any findings with appropriate caution.  
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As mentioned previously, too few participants showing cognitive change or too small a 
change within the sample also limits the scope of interpretation.  As there was limited 
cognitive change over time within the sample, it was not possible to definitively answer the 
research questions. With little previous research in the area, it had not been possible to 
predict what level of cognitive change would have been expected.  Although we cannot be 
confident that there is no effect here, we can see that in future a larger sample will be 
required to answer these important questions. Data collection is ongoing to further explore 
the aims of this study as well as the wider aims, regarding genetics, of the larger 
longitudinal study.   
 
Conclusions 
Overall this study utilised a unique sample to explore an area of increasing interest; the 
importance of walking and cognition. Although the overall cognitive stability of the 
sample limited interpretation of the results, it can be seen that the dual task measure- 
incorporating both a walking and counting component- has the potential to provide 
important information about ongoing cognitive functioning. Future research should include 
a longer time between baseline and follow up or a larger sample, where more cognitive 
decline would be expected to occur. With those who have experienced a HI being at 
increased risk of cognitive decline, it is important that the potential of this is fully 
explored.  Any tools which have the potential to screen for later difficulties could help 
ensure people receive the appropriate intervention as early as possible.   
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Appendix 1.1. Instructions for authors for submission to ‘Gait and Posture’ 
journal. 
Gait & Posture is a vehicle for the publication of up-to-date basic and clinical research on 
all aspects of locomotion and balance. 
Peer review  
This journal operates a single blind review process. All contributions will be initially 
assessed by the editor for suitability for the journal. Papers deemed suitable are then 
typically sent to a minimum of two independent expert reviewers to assess the scientific 
quality of the paper. The Editor is responsible for the final decision regarding acceptance 
or rejection of articles. The Editor's decision is final. More information on types of peer 
review. 
Introduction  
State the objectives of the work and provide an adequate background, avoiding a detailed 
literature survey or a summary of the results. 
 
1. Article types accepted are: Original Article (Full paper or Short Communication), 
Review Article, Book Review. Word limits are as follows: Full paper 3,000 words plus no 
more than 6 figures/tables in total; Short Communication 1,200 words plus no more than 3 
figures/tables in total. The word limits are non-inclusive of figures, tables, references, and 
abstracts. If the Editor feels that a paper submitted as a Full Paper would be more 
appropriate for the Short Communications section, then a shortened version will be 
requested. References should be limited to 30 for Full Papers and Reviews and 15 for Short 
Papers. A structured abstract of no more than 300 words should appear at the beginning of 
each Article. The recommended word limit for Review Papers is 6,000 words. Authors 
must state the number of words when submitting. 
2. All publications will be in English. Authors whose 'first' language is not English should 
arrange for their manuscripts to be written in idiomatic English before submission. A 
concise style avoiding jargon is preferred. 
3. Authors should supply up to five keywords that may be modified by the Editors. 
4. Authors should include a structured abstract of no more than 300 words including the 
following headings: Background, Research question, Methods, Results and Significance. 
The scientific and clinical background should be explained in 1-2 sentences. One clear 
scientifically relevant question should be derived from the background which represents 
the principle research question of the paper. The Methods section should summarise the 
core study methodology including the type of study (prospective/retrospective, intervention 
etc), procedures, number of participants and statistical methods. The Results section should 
summarise the study's main findings. The Significance section should place the results into 
context. Furthermore this section should highlight the clinical and/or scientific importance 
of the work, answering the question "so what?" This section should not simply repeat the 
study results or conclusions. 
5. Acknowledgements should be included in the title page. Include external sources of 
support. 
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6. The text should be ready for setting in type and should be carefully checked for errors. 
Scripts should be typed double-spaced on one side of the paper only. Please do not 
underline anything, leave wide margins and number every sheet. 
7. All illustrations should accompany the typescript, but not be inserted in the text. Refer to 
photographs, charts, and diagrams as 'figures' and number consecutively in order of 
appearance in the text. Substantive captions for each figure explaining the major point or 
points should be typed on a separate sheet. 
8. Tables should be presented on separate sheets of paper and labelled consecutively but 
the captions should accompany the table. 
9. Authors should also note that files containing text, figures, tables or multimedia data can 
be placed in a supplementary data file which will be accessible via ScienceDirect (see later 
section for further details). 
10. When submitting your paper please ensure that you separate any identifying author or 
institution of origin names and details and place them in the title page (with authors and 
addresses). Submissions including identifying details in the manuscript text will be 
returned to the author. 
Essential title page information  
• Title. Concise and informative. Titles are often used in information-retrieval systems. 
Avoid abbreviations and formulae where possible. 
• Author names and affiliations. Please clearly indicate the given name(s) and family 
name(s) of each author and check that all names are accurately spelled. You can add your 
name between parentheses in your own script behind the English transliteration. Present 
the authors' affiliation addresses (where the actual work was done) below the names. 
Indicate all affiliations with a lower-case superscript letter immediately after the author's 
name and in front of the appropriate address. Provide the full postal address of each 
affiliation, including the country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all stages of 
refereeing and publication, also post-publication. This responsibility includes answering 
any future queries about Methodology and Materials. Ensure that the e-mail address is 
given and that contact details are kept up to date by the corresponding author. 
• Present/permanent address. If an author has moved since the work described in the 
article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') 
may be indicated as a footnote to that author's name. The address at which the author 
actually did the work must be retained as the main, affiliation address. Superscript Arabic 
numerals are used for such footnotes. 
Highlights  
Highlights are mandatory for this journal. They consist of a short collection of bullet points 
that convey the core findings of the article and should be submitted in a separate editable 
file in the online submission system. Please use 'Highlights' in the file name and make sure 
to strictly adhere to the following specifications: include 3 to 5 bullet points (maximum 85 
characters (not words), including spaces, per bullet point). 
See http://www.elsevier.com/highlights for examples. 
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Keywords  
Immediately after the abstract, provide a maximum of 6 keywords, using American 
spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 
'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field 
may be eligible. These keywords will be used for indexing purposes. 
References  
Indicate references to the literature in the text by superior Arabic numerals that run 
consecutively through the paper in order of their appearance. Where you cite a reference 
more than once in the text, use the same number each time. References should take the 
following form: 
1. Amis AA, Dawkins GPC. Functional anatomy of the anterior cruciate ligament. J Bone 
Joint Surg [Br] 1991; 73B: 260-267 
2. Insall JN. Surgery of the Knee. New York: Churchill Livingstone; 1984 
3. Shumway-Cook A, Woollacott M. Motor Control: Theory and Practical Applications. 
Baltimore: Williams and Wilkins; 1995. 
Please ensure that references are complete, i.e. that they include, where relevant, author's 
name, article or book title, volume and issue number, publisher, year and page 
reference and comply with the reference style of Gait Posture. Only salient and significant 
references should be included. 
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Appendix 1.2 Data extraction form  
ID__________________ 
 
Participants (sample size, age range and mean, gender, ABI profile) 
 
 
 
 
Exposures (measurement of walking speed and cognition)  
 
 
 
 
Comparisons (use of control group, follow up) 
 
 
 
 
Outcomes (relationship between walking speed and cognition) 
 
 
 
 
Study design  
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Appendix 1.3.  Risk of bias rating form 
ID__________________ 
1. Methods for selecting study participants (inclusion and exclusion criteria are clear, 
adequate assurance they meet criteria of having experienced an ABI.  The sample is representative 
of the ABI group is includes.) 
 
HIGH/LOW 
 
2. Methods for measuring exposure and outcome variables (use of standardised 
measures) 
Walking speed 
HIGH/LOW 
Cognition  
HIGH/LOW 
 
3. Design specific sources of bias (appropriate methods outlined to deal with any design 
specific issues such as biased loss to follow or blinding) 
 
 HIGH/LOW 
 
4. Methods to control confounding (appropriate consideration of potential confounders on 
the relationship between walking speed and cognition) 
 
 HIGH/LOW 
 
5. Statistical methods (appropriate use of statistical analysis) 
 
 HIGH/LOW 
 
6. Conflict of interest (declarations of conflict of interest or identification of funding sources) 
 
 HIGH/LOW 
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Abstract 
 
Background 
Late after severe head injury there can be change in disability for better or worse including 
increased risk of neurodegeneration.  Neuropsychological assessment to detect change in 
function after head injury (HI) can be time consuming, difficult to access and expensive 
and a simple assessment that might be carried out in primary care would facilitate triage.  
Walking speed is a predictor of cognitive function following a stroke and in those with 
dementia.  Although those with severe HI are at increased risk of cognitive decline, it is not 
known whether walking speed predicts cognitive decline in this at risk group.  
 
Aim 
To determine whether walking speed identifies cognitive change late after severe head 
injury.  
 
Methods 
This study will follow up to 100 participants who experienced a severe head injury on 
average 25 years previously and who took part in a study on walking speed and cognitive 
ability 2 years before the present study.  At follow-up cognitive ability, walking speed and 
measures of physical and mental health will be repeated.   
Analysis: Regression will be used to explore whether walking speed at baseline predicts 
cognitive change at follow up.  
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Introduction 
It has been argued that severe head injury (HI) is a risk factor for neurodegeneration late 
after injury (Gupta, 2016).  Dunning et al (2016) conducted a meta-analysis of 21 studies, 
in HI survivors.  When compared to controls, those with a HI had significant deficits in 
memory and visuospatial skills. The impact of HI may be long lasting and may put people 
at higher risk of cognitive decline later in life (Ozen et al 2015).  Wang et al (2012) 
conducted a retrospective cohort study on 269,550 people; at five year follow up an 
increased risk of dementia was found in individuals with HI. This enhanced risk can cause 
ongoing concern to the individual and their loved ones.  
Research into predictors of cognitive decline has explored the importance of gait.  Gait 
incorporates motor, perceptual and cognitive processes and encompasses the phases which 
make up the walking cycle (Ayyappa, 1997).  Some studies look at gait speed alone while 
others utilise it as part of a dual task whereby participants are asked to walk while doing 
another cognitively demanding task, for example, talking.  Of the following six studies, 
two utilised a dual task procedure (Doi et al and Assayag et al), whereas four looked at gait 
speed alone.  Miekle et al (2012) conducted a large population based study (n=1478) on 
walking speed as a predictor of cognitive decline. They found that faster walking speed 
was associated with better performance in memory, executive function and global 
cognition when followed for 20 years. This is in line with findings from a number of 
studies showing an association between walking and cognition (Callisaya et al, 2015 & 
Buracchio et al, 2010). This association has been shown in several diagnostic groups 
including those with mild cognitive impairment (Doi et al, 2014), stroke (Assayag et al, 
2015) and dementia (Verghese et al, 2016).  Three of these studies (Doi et al, Buracchio et 
al & Assayag et al) looked at an association between gait and a measure of cognitive 
function.  The other three studies (Callisaya et al, Verghese et al, & Miekle et al) looked 
longitudinally at how gait was associated with cognitive decline over time. 
It is not known whether the association between gait and cognitive change is evident in 
people who have a severe HI. Walking speed offers the potential of a quick, easy and 
naturalistic method of detecting risk for cognitive change.  It is known that those with 
severe HI are at increased risk of cognitive change over time (Millar et al, 2003; Whitnall 
et al 2006); hence exploring the potential role of walking speed in predicting this risk has 
important clinical and research implications. If it was established that walking speed 
predicts cognitive change in this at risk group, then it could be used as a tool to triage 
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patients presenting in primary care to further screening of neuropsychological assessment.  
This would help ensure they received an appropriate intervention as quickly as possible.  
2.  Aims and hypotheses  
2.1 Aim 
The aim is to explore walking speed as an assessment for cognitive change late after severe 
head injury. If an association between walking speed and cognitive change is found, then 
an additional aim will be to investigate whether a walking speed cut off can be established 
to capture those with cognitive decline (i.e. with good sensitivity and moderate/ good 
specificity). 
2.2 Hypothesis 
Primary: Walking speed at baseline (as measured by a dual task) is associated with 
cognitive change (as measured by the difference in cognitive scores between baseline and 
2-year follow up).   
Secondary: A reduction in walking speed between assessment and reassessment will be 
associated with a greater decline in cognitive test performance. 
3. Plan of Investigation  
3.1 Participants 
 
Participants will be recruited from two historical research cohorts that recruited people 
with a severe HI (Millar et al, 2003; Teasdale et al, 2005) of whom 190 were further 
assessed between 2015 and 2017.  This project will form part of a larger follow up study of 
these 190 participants, at two year follow up, 2017-2019.   
3.2 Inclusion and exclusion criteria 
Participants will be included if they took part in the baseline gait assessment in 2015-17.  
All will have a history of severe HI and baseline data on their cognitive ability and walking 
speed as assessed in 2015-2017.   All participants must be considered capable of giving 
informed consent.   
 
Participants will be excluded if they have suffered a serious neurological event since the 
baseline assessment (e.g. a stroke or further HI), a physical injury affecting walking or are 
not capable of being assessed. 
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3.3 Recruitment procedures 
All participants recruited to the first phase of this study will be asked to take part in a 
follow up assessment, approximately two years after their last (‘baseline’) assessment.  
Although all 190 participants will be contacted as part of the larger study, data collection 
for this MRP will only include those eligible for follow up between June 2017 and April 
2018.  This will include up to 100 participants.  The follow-ups will be carried out by RP 
from August/September 2017 and by a research worker who was involved in the baseline 
study. 
 
3.4 Measures 
Background questionnaire -This includes basic demographic data, including the 
participant’s age, gender and occupation.  In addition, it will explore whether the person 
has experienced any significant life events since their previous assessment.  
 
Walking measure 
Dual task: A dual task (DT) procedure requires an individual to perform two tasks 
simultaneously, and can be compared to performance in single task (ST) conditions 
(McCulloch, 2007), allowing by subtraction, a response cost to be calculated. In this 
instance, participants will first be timed to walk 6 metres (ST) and then to walk and count 
backwards from 100 in 3s for 30 seconds.  In addition to completing these tasks singly, 
participants will also complete them simultaneously (i.e. walking and counting at the same 
time).  This is the DT, and considers factors that may affect speed in the single task 
condition.  In the DT condition, there are a number of different outcomes.  Walking may 
be slower or less stable, or counting may be slower or less accurate.  Poorer performance in 
either walking and/or counting could occur. Reduced performance in the DT condition is 
described as dual task cost (calculated as DT-ST/ST). Dual task cost may represent 
impaired capacity to share cognitive resources between walking and an attention 
demanding task.  Both dual task walking speed and dual task cost will be included in 
analyses.  
 
Disability Assessment 
Glasgow Outcome Scale Extended (GOSE, Jennett & Bond, 1975)-A global scale for 
functional outcome that uses a structured interview to rate patient status into one of eight 
categories; ranging from dead to good recovery. 
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Cognitive measures 
Mini Mental State Examination (MMSE, Folstein et al, 1975)- A screening tool to assess 
general cognitive function.  It includes items of orientation, registration, short term 
memory and language functioning.  
 
Verbal paired associates test (WMS-R)-A subtest within the WMS-R which assess episodic 
memory.  Participants are given a list of two linked words and asked to remember which 
word is associated with which.  
 
STROOP test-A measure of executive function where the participant is asked to name the 
colour a word is printed in when the word itself is the name of another colour.  The score is 
a measure of time.   
 
Symbol digit modalities test -A screening tool for cognitive impairment, the participant is 
asked to use a reference key to pair specific numbers with given geometric figures. The 
score is a measure of time.   
 
Wellbeing measures 
Hospital Anxiety and Depression Scale (HADS, Zigmond & Snaith, 1983) - A fourteen 
item questionnaire which includes 7 items relating to anxiety and 7 items relating to 
depression. 
 
General Health Questionnaire-28 (Goldberg, 1978) -A measure of emotional distress in 
medical settings. This present study will include items one and two from the questionnaire, 
which ask the participant to report on their current health, and health over the past 12 
months using multiple choice responses.   
 
Alcohol Use Disorders Identification Test (Bohn et al, 1995) -A ten question checklist to 
determine if a person may be at risk for alcohol abuse problems. 
 
3.5 Design 
The study is a longitudinal within group study.  Walking speed at baseline will be explored 
as a predictor of risk of cognitive change at 2 year follow up.   
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3.6 Research procedures 
All potential participants (n=100) will be contacted by letter from Professor McMillan with 
the study information, 2 years following their baseline assessment (2017-2018).  They will 
be asked to read the information and return the enclosed consent form in a prepaid 
envelope should they wish to participate. They will then be contacted by phone to ensure 
they meet the inclusion criteria and to schedule the assessment.  The participant will 
complete the measures when they attend. They will be provided with travel expenses and 
supermarket vouchers to the value of £15 to compensate them for their time. The data will 
be stored securely in line with the Data Protection Act.   
 
3.7 Data analysis 
The primary research question is to explore whether walking speed during DT predicts 
cognitive change late after HI.  Cognitive change is the primary outcome variable.  A 
composite score for cognitive ability will be created by creating and combining Z scores 
for the participant’s performance on the verbal paired associates, Stroop and symbol digit 
modalities tasks.  These will be created initially using the means and standard deviations of 
the whole sample at baseline. Change in (i) this composite score, and (ii) change in MMSE 
score are the primary outcome variables measuring cognitive change.  Regression analysis 
will then be conducted to explore the relationship between walking speed at baseline and 
cognitive change. Age at baseline and number of years in education will be included in the 
model at baseline.  If an association is found, sensitivity and specificity analysis will then 
be conducted to explore whether a clinically effective cut off score can be established to 
capture those showing cognitive decline.  
 
If walking speed predicts change over time, then it is also of interest to explore change in 
health over time.  Disability (GOSE), perceived health (GHQ-28) and mental health 
(HADS) will therefore also be explored as outcome variables.  Change in a participant’s 
alcohol use (AUDIT) will be explored as a potential confounder and controlled for if 
necessary. 
 
A secondary RQ is that change in walking speed between baseline and follow-up will be 
associated with change in cognitive function. There would be an expectation that if there is 
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general decline as indicated by cognitive function then this would also be reflected in the 
predictor variable (i.e. that DT walking speed should also decrease). 
3.8 Justification of sample size 
The key analysis on this study is determination of the association between gait measures at 
baseline and change in cognition/outcome at time 2. There has not been research on gait 
and HI that is relevant to estimating sample size required for this study. Existing studies on 
gait and cognitive decline have largely used healthy adults or older adults at relatively high 
risk of cognitive decline, with gait as an outcome measure. There is also limited research 
on change in function over time after HI in the same participants, and this has been at 
different time points after injury.  For example, Millar et al (2003), reported deterioration 
on the GOSE between 6 months and on average 18 years after injury in almost a third of 
396 severe HI patients. Whitnall et al (2006) reported improvement or deterioration on the 
GOSE between 1 and 5-7 year follow-ups 54% of HI participants.  
G Power indicates that with alpha set at 0.05, power at 0.8, and a medium effect size (f) of 
0.30 that 82 participants are needed (Faul et al, 2009).  In the absence of published 
literature relevant to this study’s aims, Ferguson (2009) suggests that the minimum effect 
size needed for practical significance in social science research is 0.2; with an approximate 
n of 102 proposed here, an effect of 0.27 could be detected.  If an effect size of 0.3 was 
achieved with a sample size of 100 then this study would have 0.88 power. 
 
3.9 Settings and equipment 
Research assessments will take place in the Clinical Research Facility within Glasgow 
Royal Infirmary.  Questionnaire measures will be collected on paper.  In addition, a 
marked out 6 metre length and stopwatch, will be required to complete the dual task.  
4. Health and Safety Issues  
4.1 Researcher safety issues 
There are no known researcher safety issues.   Data will be collected in NHS buildings 
where standard safety protocols will be adhered to.  All participants have already been 
assessed by the research team in the past 2 years. 
4.2 Participant safety issues 
There are no known participant safety issues.  All participants will have undergone a 
similar assessment 2 years prior.    There is a short task where they are asked to walk a 
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short distance, however the exclusion criteria excluding anyone with walking difficulties 
should minimise any potential risk in this task.  
5. Ethical Issues 
The study has ethical approval from the West of Scotland NHS Research Ethics committee 
(ref 14/WS/1145).  The participants will all be previous research participants, who have 
given their consent to be contacted again for future studies.  Furthermore, the procedure 
will be similar to one which they have already undertaken. Written consent will be 
obtained.  Participants will be free to withdraw from the research at any time.  
A potential ethical issue may arise if someone shows significant cognitive decline.  Any 
cognitive change will be primarily explored using the MMSE, an established screening 
tool.  If someone presents with significant decline, as assessed using age and education 
normed clinical cut offs (Lezak, 2004), they will be asked to consent for their results being 
shared with their GP.  
As ethics approval has already been obtained, I will complete an IRAS form to be checked 
and approved by my supervisors in relation to achieving this research competency. 
6. Financial Issues 
The main costs for this study are measures, participant travel expenses and honorarium, 
printing and postage costs.  A full breakdown is included in the attached equipment form.  
Participant costs will be covered by the main research project. 
  
7. Timetable   
The proposal for study will be finalised by July 2017.  The aim will be to commence data 
collection in August/September 2017 until April 2018.  The data will then be analysed and 
results written up in preparation to submit in July 2018.   
 
8. Practical Applications 
It is hoped that the results will help in identifying assessment a simple test that can predict 
risk of cognitive change late after severe HI.  Being able to predict cognitive change in an 
‘at risk’ group provides an opportunity for early intervention.  Individuals and their 
families can be offered support earlier and it may provide more opportunities for better 
treatment outcomes.   
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Appendix 2.3 Participant Information Sheet 
 
PARTICIPANT INFORMATION SHEET 
TEAFOL 17 
 
An Investigation of Heterogeneity of Outcome   
Late after Severe Head Injury 
 
You recently helped us in a research study on head injury and we would like you to help us 
once more. Before you decide it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. Ask us if there is anything that is not clear 
or if you would like more information. Take time to decide whether or not you wish to take 
part.  
 
What is the purpose of the study?   
We are carrying out studies on head injury to investigate why outcome can be different in 
different people and why, in some, disabilities can change over time.   
 
Why have I been chosen?  
You have been chosen because you took part in a study with us before on head injury about 
two years ago and seeing you again will help us to understand whether there has been any 
change in your health or abilities since we saw you last. 
 
Do I have to take part?  
It is up to you to decide whether or not to take part. You will be given this information sheet 
to keep and will be asked to sign a consent form. If you decide to take part, you are still 
free to withdraw at any time and without giving a reason. 
 
What will happen to me if I take part? 
You will be invited to attend for a single assessment lasting about 60 minutes. This is much 
the same as the last assessment but a bit shorter. It will involve:  
(i) a brief interview about recent health and history of head injury (ii) questionnaires about 
psychological wellbeing; (iii) tests of cognition such as concentration and memory; (iv) basic 
physical measurements such as lung capacity; (v) a 10ml blood sample (about two 
teaspoons) which we will use to check for markers we think may be relevant to outcome 
after a head injury. You will be offered vouchers for £20 that you can use in Tesco, Asda, 
Sainsburys or Boots to compensate you for your time. 
 
Where will the assessment take place? 
The assessment will take place in Glasgow. If you are unable to attend we can obtain some 
information by telephone.  
 
What do I have to do? 
You just have to attend for the assessment and not have consumed alcohol on that day. 
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What are the possible disadvantages and risks of taking part? 
There are no particular disadvantages to taking part. There can be temporary bruising at 
the needle site, but only occasionally do some people feel faint when a blood sample is 
being taken. 
 
What are the possible benefits of taking part? 
You will receive no direct benefit from taking part. The information collected in the study 
will give us a better understanding of any long term effects of head injury and may allow 
us to make recommendations for health service improvements.  
 
Will my taking part in this study be kept confidential? 
All information collected about you during the research will be kept strictly confidential. 
You will be identified by an identity number, and any information about you will have 
your name and address removed so that you cannot be recognised from it.  Scientific 
publications arising from the research will not identify any individual.  
 
What will happen to the results of the research study? 
When the project is completed, the findings will be submitted for publication in peer 
reviewed international journals.  
 
Who is organising and funding the research? 
The research is organised by the University of Glasgow. The research is funded by the 
University of Glasgow, the Chief Scientist Office and by the Sackler Foundation. 
 
Who has reviewed the study? 
The project has been reviewed by the University of Glasgow College of Medical Veterinary 
and Life Sciences and by the West of Scotland NHS Ethics Committee. 
 
Contact for Further Information 
You can contact Claire McLeod or Dr Lin Maclean who will be arranging and carrying out 
the assessments: 0141 211 3901; claire.mcleod@glasgow.ac.uk; 
linda.maclean@glasgow.ac.uk or Professor Tom McMillan 
thomas.mcmillan@glasgow.ac.uk (0141 211 0354) who is organising the research. 
 
 
 
 
Thank you for considering this request to take part in the study. 
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Appendix 2.4 Consent form 
 
 
 Participant ID Number:      
TEAFOL 17 
CONSENT FORM 
 
Title: An Investigation of Heterogeneity of Outcome   
Late after Severe Head Injury 
 
            Please initial box 
 
1) I confirm that I have read and understand the information sheet dated March 2017  
(Version 3) for the above study and have had the opportunity to ask questions. 
 
2) I understand that my participation is voluntary and that I am free to withdraw at             
 any time, without giving any reason and without my legal rights being affected.  
 
3) I agree to take part in the above study. 
                                                                                       
4) I agree that the researchers can obtain NHS records pertaining to any hospital   
 admission that I have had.  
 
5) I understand that anonymous data collected during the study, may be looked at by  
individuals from University of Glasgow, from regulatory authorities or from the 
NHS Board, where it is relevant to my taking part in this research. I give permission 
for these individuals to have access to my records.  
 
6)       I agree to my data being retained for 10 years, including following loss of capacity. 
I understand this is for the purpose of future research ad that all data will be  
destroyed confidentially after this period.           
 
7)  I agree that I can be contacted about future studies on head injury.  
 
 
 
 
           
Name of participant Date Signature 
 
 
    
Name of Person taking consent  Date Signature 
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Appendix 2.5 Regression assumptions 
Prior to conducting the regression, it was important, firstly, to investigate whether the 
model fits the observed data well or whether instead it is being influenced by a small 
number of cases, and secondly to see if the model can be generalised to other samples.  
The process which was worked through is outlined in Field (2009).   
Firstly, an investigation was carried out into how accurate the regression model was.  This 
was firstly done by looking for outliers and residuals.  It would be expected that 95% of 
cases to have standardised residuals within ±2, with approximately 5% outside of these 
limits.  In a sample of 48, there were 2 cases (4.17%) lying outside these limits in the 
MMSE regression and 1 case (2.08%) in the Z score regression, therefore the sample 
appeared to conform to what would be expected for a fairly accurate model.  There were 
no cases with a standardised residual greater than 3, so none which raise concerns.  In 
addition, there was an investigation into whether certain cases were having a large effect 
on the model using Cook’s distance, where values greater than 1 give cause for concern.  
The highest Cook’s value within the sample was 0.331, so this does not appear to be a 
problem.   
Secondly it was important to investigate whether the model could be generalised to other 
samples, so that it could be assumed that any findings would be true for a wider 
population.  For a regression model to generalised, it is necessary to make sure that 
underlying assumptions have been met, again as outlined in Field (2009): 
Variable types: The variables are all measures at the interval level; 
Non-zero variance: The predictors all have some variation in value; 
No perfect multicollinearity: The independent variables to not correlate too highly with 
each other, with none have correlations >0.9.  In addition, there are no variance inflation 
factors (VIF) greater than 10 or below 0.2, therefore no multicollinearity in the sample 
could be assumed; 
Predictors are uncorrelated with ‘external variables’: There are no known variables 
which have not been included in the regression model but which correlate with the 
predictors and influence the outcome variable;  
Homoscedasticity: scatter plots show that the residuals at each level of the predictors have 
similar levels of variance; 
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Independent errors: for any 2 observations, the residual terms are uncorrelated, as tested 
by the Durbin-Watson test, where a value of 2 means the residuals are uncorrelated; the 
values for this analysis were 1.915 (z score regression) and 2.019 (MMSE regression) 
which gave no cause for concern. 
Normally distributed errors: the residuals in the model are random, showing normally 
distributed variables with a mean of 0;  
Independence: all the values of the outcome variable are independent; 
Linearity:  the mean value of the outcome variable for each increment of the predictor lies 
along a straight line. 
 
Overall, the assumptions for conducting regression with this sample were met: it could be 
seen that the model was a good fit for the data and should be generalised to other samples.  
It was therefore possible to analyse the data as planned.  
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Appendix 2.6 Additional analysis 
Dual task and STMBT.  Univariate regression analysis 
 
 
 Variable B SE B Significance 
Dual task walking Shape Memory -0.00 0.00 0.27 
Memory binding 0.00 0.00 0.57 
Memory binding cost -0.00 0.01 0.89 
Dual task walking 
cost 
Shape Memory -0.02 0.03 0.46 
Memory binding 0.05 0.05 0.33 
Memory binding cost -0.04 0.05 0.48 
Dual task counting Shape Memory 0.06 0.03 0.07 
Memory binding -0.07 0.07 0.32 
Memory binding cost 0.06 0.06 0.33 
Dual task counting 
cost 
Shape Memory 0.01 0.02 0.77 
Memory binding -0.02 0.03 0.54 
Memory binding cost 0.01 0.03 0.77 
